{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:32:33Z","timestamp":1788942753825,"version":"build-2803163510"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000861","name":"Sparks","doi-asserted-by":"publisher","award":["12WTUCL02"],"award-info":[{"award-number":["12WTUCL02"]}],"id":[{"id":"10.13039\/501100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["099083\/Z\/12\/Z"],"award-info":[{"award-number":["099083\/Z\/12\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011088","name":"UCL Hospitals Charitable Foundation","doi-asserted-by":"publisher","award":["E008"],"award-info":[{"award-number":["E008"]}],"id":[{"id":"10.13039\/100011088","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Thalassaemia Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In utero gene therapy (IUGT) to the fetal hematopoietic compartment could be used to treat congenital blood disorders such as \u03b2-thalassemia. A humanised mouse model of \u03b2-thalassemia was used, in which heterozygous animals are anaemic with splenomegaly and extramedullary hematopoiesis. Intrahepatic <jats:italic>in utero<\/jats:italic> injections of a \u03b2 globin-expressing lentiviral vector (GLOBE), were performed in fetuses at E13.5 of gestation. We analysed animals at 12 and 32 weeks of age, for vector copy number in bone marrow, peripheral blood liver and spleen and we performed integration site analysis. Compared to noninjected heterozygous animals IUGT normalised blood haemoglobin levels and spleen weight. Integration site analysis showed polyclonality. The left ventricular ejection fraction measured using magnetic resonance imaging (MRI) in treated heterozygous animals was similar to that of normal non-\u03b2-thalassemic mice but significantly higher than untreated heterozygous thalassemia mice suggesting that IUGT ameliorated poor cardiac function. GLOBE LV-mediated IUGT normalised the haematological and anatomical phenotype in a heterozygous humanised model of \u03b2-thalassemia.<\/jats:p>","DOI":"10.1038\/s41598-019-48078-4","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T10:03:02Z","timestamp":1565604182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-8405","authenticated-orcid":false,"given":"Panicos","family":"Shangaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros P.","family":"Loukogeorgakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Flouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence H.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanrun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0892-9204","authenticated-orcid":false,"given":"Simon","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Bakhamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durrgah Latchumi","family":"Ramachandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Maghsoudlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-4730","authenticated-orcid":false,"given":"Simon N.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-6426","authenticated-orcid":false,"given":"Ayad","family":"Eddaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3185-5314","authenticated-orcid":false,"given":"Michael N.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1659-0207","authenticated-orcid":false,"given":"Paolo","family":"De Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-6140","authenticated-orcid":false,"given":"Anna L.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"48078_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","volume":"10","author":"B Modell","year":"2008","unstructured":"Modell, B. et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 10, 42 (2008).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"48078_CR2","doi-asserted-by":"crossref","unstructured":"Modell Bernadette & Darlison Matthew. Global epidemiology of haemoglobin disorders and derived\\nservice indicators. Bull. World Health Organ. 86, 480\u2013487 (2008).","DOI":"10.2471\/BLT.06.036673"},{"key":"48078_CR3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund, D. & Rachmilewitz, E. Beta-thalassemia. N. Engl. J. Med. 353, 1135\u201346 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"48078_CR4","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"Eliezer A. Rachmilewitz","year":"2011","unstructured":"Rachmilewitz, E. A. & Giardina, P. J. How I treat thalassemia. Blood 3479\u20133488, https:\/\/doi.org\/10.1182\/blood-2010-08-300335 (2011).","journal-title":"Blood"},{"key":"48078_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1196\/annals.1345.002","volume":"1054","author":"DJ Weatherall","year":"2005","unstructured":"Weatherall, D. J. Keynote address: The challenge of thalassemia for the developing countries. Ann. N. Y. Acad. Sci. 1054, 11\u20137 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"48078_CR6","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood-2010-08-300723","volume":"117","author":"A Wilber","year":"2011","unstructured":"Wilber, A. et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of \u03b2-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood 117, 2817\u201326 (2011).","journal-title":"Blood"},{"key":"48078_CR7","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1126\/science.1065806","volume":"294","author":"R Pawliuk","year":"2001","unstructured":"Pawliuk, R. et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 294, 2368\u201371 (2001).","journal-title":"Science"},{"key":"48078_CR8","doi-asserted-by":"crossref","first-page":"e32345","DOI":"10.1371\/journal.pone.0032345","volume":"7","author":"L Breda","year":"2012","unstructured":"Breda, L. et al. Therapeutic hemoglobin levels after gene transfer in \u03b2-thalassemia mice and in hematopoietic cells of \u03b2-thalassemia and sickle cells disease patients. PLoS One 7, e32345 (2012).","journal-title":"PLoS One"},{"key":"48078_CR9","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1073\/pnas.0904689106","volume":"106","author":"L Ye","year":"2009","unstructured":"Ye, L. et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. USA 106, 9826\u201330 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48078_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1345.030","volume":"1054","author":"P Malik","year":"2005","unstructured":"Malik, P., Arumugam, P. I., Yee, J.-K. & Puthenveetil, G. Successful correction of the human Cooley\u2019s anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator. Ann. N. Y. Acad. Sci. 1054, 238\u201349 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"48078_CR11","first-page":"69","volume":"6","author":"A Finotti","year":"2015","unstructured":"Finotti, A. et al. Recent trends in the gene therapy of \u03b2-thalassemia. J. Blood Med. 6, 69\u201385 (2015).","journal-title":"J. Blood Med."},{"key":"48078_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/emmm.201000083","volume":"2","author":"EA Roselli","year":"2010","unstructured":"Roselli, E. A. et al. Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients. EMBO Mol. Med. 2, 315\u201328 (2010).","journal-title":"EMBO Mol. Med."},{"key":"48078_CR13","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.1073\/pnas.0711666105","volume":"105","author":"A Miccio","year":"2008","unstructured":"Miccio, A. et al. In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of \u03b2-thalassemia. Proc. Natl. Acad. Sci. USA 105, 10547\u201310552 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48078_CR14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/MCB.00725-10","volume":"31","author":"SC McConnell","year":"2011","unstructured":"McConnell, S. C., Huo, Y., Liu, S. & Ryan, T. M. Human globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal development. Mol. Cell. Biol. 31, 876\u201383 (2011).","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"48078_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05547.x","volume":"1202","author":"Yongliang Huo","year":"2010","unstructured":"Huo, Y. et al. Humanized mouse models of Cooley\u2019s anemia: Correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology. In Annals of the New York Academy of Sciences 1202, 45\u201351 (2010).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"48078_CR16","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1182\/blood-2008-12-197012","volume":"113","author":"Y Huo","year":"2009","unstructured":"Huo, Y., McConnell, S. C. & Ryan, T. M. Preclinical transfusion-dependent humanized mouse model of beta thalassemia major. Blood 113, 4763\u201370 (2009).","journal-title":"Blood"},{"key":"48078_CR17","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/bloodadvances.2017009449","volume":"1","author":"Y Huo","year":"2017","unstructured":"Huo, Y. et al. Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with \u03b2-thalassemia major. Blood Adv. 1, 2421\u20132432 (2017).","journal-title":"Blood Adv."},{"key":"48078_CR18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson, A. A. et al. Gene Therapy in Patients with Transfusion-Dependent \u03b2-Thalassemia. N. Engl. J. Med. 378, 1479\u20131493 (2018).","journal-title":"N. Engl. J. Med."},{"key":"48078_CR19","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.M805681200","volume":"284","author":"Y Huo","year":"2009","unstructured":"Huo, Y. et al. Humanized mouse model of Cooley\u2019s anemia. J. Biol. Chem. 284, 4889\u20134896 (2009).","journal-title":"J. Biol. Chem."},{"key":"48078_CR20","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.1073\/pnas.212507099","volume":"99","author":"S Imren","year":"2002","unstructured":"Imren, S. et al. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 99, 14380\u20135 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48078_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32832990a4","volume":"16","author":"S Rivella","year":"2009","unstructured":"Rivella, S. Ineffective erythropoiesis and thalassemias. Curr. Opin. Hematol. 16, 187\u201394 (2009).","journal-title":"Curr. Opin. Hematol."},{"key":"48078_CR22","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood-2004-04-1427","volume":"104","author":"G Puthenveetil","year":"2004","unstructured":"Puthenveetil, G. et al. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood 104, 3445\u201353 (2004).","journal-title":"Blood"},{"key":"48078_CR23","volume":"7","author":"LH Jackson","year":"2017","unstructured":"Jackson, L. H. et al. Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of \u03b2-thalassemia. Sci. Rep. 7, 43439 (2017).","journal-title":"Sci. Rep."},{"key":"48078_CR24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jmri.20915","volume":"25","author":"MA Westwood","year":"2007","unstructured":"Westwood, M. A. et al. Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. J. Magn. Reson. Imaging 25, 1147\u20131151 (2007).","journal-title":"J. Magn. Reson. Imaging"},{"key":"48078_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2003-08-2841","volume":"104","author":"BA Davis","year":"2004","unstructured":"Davis, B. A., O\u2019Sullivan, C., Jarritt, P. H. & Porter, J. B. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 104, 263\u2013269 (2004).","journal-title":"Blood"},{"key":"48078_CR26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ajh.23219","volume":"87","author":"A Maggio","year":"2012","unstructured":"Maggio, A. et al. Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients. American Journal of Hematology 87, 732\u2013733 (2012).","journal-title":"American Journal of Hematology"},{"key":"48078_CR27","first-page":"407","volume":"4","author":"T He","year":"2014","unstructured":"He, T. Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart. Quant. Imaging Med. Surg. 4, 407\u2013412 (2014).","journal-title":"Quant. Imaging Med. Surg."},{"key":"48078_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","volume":"72","author":"EWFWFW Alton","year":"2017","unstructured":"Alton, E. W. F. W. F. W. et al. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax 72, 137\u2013147 (2017).","journal-title":"Thorax"},{"key":"48078_CR29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ymthe.2005.07.358","volume":"12","author":"M Themis","year":"2005","unstructured":"Themis, M. et al. Oncogenesis Following Delivery of a Nonprimate Lentiviral Gene Therapy Vector to Fetal and Neonatal Mice. Mol. Ther. 12, 763\u2013771 (2005).","journal-title":"Mol. Ther."},{"key":"48078_CR30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/mt.2012.224","volume":"21","author":"A Nowrouzi","year":"2013","unstructured":"Nowrouzi, A. et al. The Fetal Mouse Is a Sensitive Genotoxicity Model That Exposes Lentiviral-associated Mutagenesis Resulting in Liver Oncogenesis. Mol. Ther. 21, 324\u2013337 (2013).","journal-title":"Mol. Ther."},{"key":"48078_CR31","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1007\/s13277-014-2542-4","volume":"35","author":"NN Kabir","year":"2014","unstructured":"Kabir, N. N., Sun, J., R\u00f6nnstrand, L. & Kazi, J. U. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling. Tumor Biol. 35, 10581\u201310589 (2014).","journal-title":"Tumor Biol."},{"key":"48078_CR32","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/MCB.22.13.4567-4578.2002","volume":"22","author":"DL Krebs","year":"2002","unstructured":"Krebs, D. L. et al. SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation. Mol. Cell. Biol. 22, 4567\u20134578 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"48078_CR33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini, E. et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24, 687\u2013696 (2006).","journal-title":"Nat. Biotechnol."},{"key":"48078_CR34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/mt.2011.19","volume":"19","author":"CC Bartholomae","year":"2011","unstructured":"Bartholomae, C. C. et al. Lentiviral Vector Integration Profiles Differ in Rodent Postmitotic Tissues. Mol. Ther. 19, 703\u2013710 (2011).","journal-title":"Mol. Ther."},{"key":"48078_CR35","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1073\/pnas.96.23.13324","volume":"96","author":"GS Lipshutz","year":"1999","unstructured":"Lipshutz, G. S., Sarkar, R., Flebbe-Rehwaldt, L., Kazazian, H. & Gaensler, K. M. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc. Natl. Acad. Sci. USA 96, 13324\u20139 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48078_CR36","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1182\/blood-2004-02-0627","volume":"104","author":"SN Waddington","year":"2004","unstructured":"Waddington, S. N. et al. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104, 2714\u201321 (2004).","journal-title":"Blood"},{"key":"48078_CR37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","volume":"9","author":"NS Dejneka","year":"2004","unstructured":"Dejneka, N. S. et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol. Ther. 9, 182\u20138 (2004).","journal-title":"Mol. Ther."},{"key":"48078_CR38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1525-0016(03)00234-X","volume":"8","author":"J Seppen","year":"2003","unstructured":"Seppen, J. et al. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol. Ther. 8, 593\u20139 (2003).","journal-title":"Mol. Ther."},{"key":"48078_CR39","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1242\/dev.01169","volume":"131","author":"M Rucker","year":"2004","unstructured":"Rucker, M. et al. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131, 3007\u201319 (2004).","journal-title":"Development"},{"key":"48078_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mt.2012.135","volume":"21","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Intra-amniotic transient transduction of the periderm with a viral vector encoding TGF\u03b23 prevents cleft palate in Tgf\u03b23(\u2212\/\u2212) mouse embryos. Mol. Ther. 21, 8\u201317 (2013).","journal-title":"Mol. Ther."},{"key":"48078_CR41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2013.214","volume":"25","author":"DJ Carr","year":"2014","unstructured":"Carr, D. J. et al. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. Hum. Gene Ther. 25, 375\u201384 (2014).","journal-title":"Hum. Gene Ther."},{"key":"48078_CR42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","volume":"27","author":"AM Swanson","year":"2016","unstructured":"Swanson, A. M. et al. Maternal Therapy with Ad.VEGF-A165 Increases Fetal Weight at Term in a Guinea-Pig Model of Fetal Growth Restriction. Hum. Gene Ther. 27, 997\u20131007 (2016).","journal-title":"Hum. Gene Ther."},{"key":"48078_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","volume":"406","author":"C May","year":"2000","unstructured":"May, C. et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406, 82\u20136 (2000).","journal-title":"Nature"},{"key":"48078_CR44","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1182\/blood-2010-01-263582","volume":"117","author":"O Negre","year":"2011","unstructured":"Negre, O. et al. Correction of murine \u03b2-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion. Blood 117, 5321\u201331 (2011).","journal-title":"Blood"},{"key":"48078_CR45","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood-2002-10-3305","volume":"101","author":"S Rivella","year":"2003","unstructured":"Rivella, S., May, C., Chadburn, A., Rivi\u00e8re, I. & Sadelain, M. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 101, 2932\u20139 (2003).","journal-title":"Blood"},{"key":"48078_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.trsl.2012.12.011","volume":"161","author":"A Dong","year":"2013","unstructured":"Dong, A., Rivella, S. & Breda, L. Gene therapy for hemoglobinopathies: progress and challenges. Transl. Res. 161, 293\u2013306 (2013).","journal-title":"Transl. Res."},{"key":"48078_CR47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1196509","volume":"330","author":"JE Mold","year":"2010","unstructured":"Mold, J. E. et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 330, 1695\u20139 (2010).","journal-title":"Science"},{"key":"48078_CR48","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.4049\/jimmunol.0903127","volume":"185","author":"TD Burt","year":"2010","unstructured":"Burt, T. D., Seu, L., Mold, J. E., Kappas, A. & McCune, J. M. Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin. J. Immunol. 185, 5279\u20135288 (2010).","journal-title":"J. Immunol."},{"key":"48078_CR49","first-page":"293","volume":"25","author":"DE Harrison","year":"1997","unstructured":"Harrison, D. E., Zhong, R. K., Jordan, C. T., Lemischka, I. R. & Astle, C. M. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp. Hematol. 25, 293\u2013297 (1997).","journal-title":"Exp. Hematol."},{"key":"48078_CR50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mthe.2000.0255","volume":"3","author":"AF Tarantal","year":"2001","unstructured":"Tarantal, A. F. et al. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems. Mol. Ther. 3, 128\u201338 (2001).","journal-title":"Mol. Ther."},{"key":"48078_CR51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymthe.2004.09.009","volume":"11","author":"CD Porada","year":"2005","unstructured":"Porada, C. D. et al. Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol. Ther. 11, 284\u2013293 (2005).","journal-title":"Mol. Ther."},{"key":"48078_CR52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/mthe.2002.0681","volume":"6","author":"TC MacKenzie","year":"2002","unstructured":"MacKenzie, T. C. et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol. Ther. 6, 349\u2013358 (2002).","journal-title":"Mol. Ther."},{"key":"48078_CR53","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.ymthe.2017.04.003","volume":"25","author":"CNZ Mattar","year":"2017","unstructured":"Mattar, C. N. Z. et al. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model. Mol. Ther. 25, 1843\u20131853 (2017).","journal-title":"Mol. Ther."},{"key":"48078_CR54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1196\/annals.1345.007","volume":"1054","author":"A Bank","year":"2005","unstructured":"Bank, A., Dorazio, R. & Leboulch, P. A phase I\/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann. N. Y. Acad. Sci. 1054, 308\u201316 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"48078_CR55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/hum.2010.045","volume":"22","author":"MC Frittoli","year":"2011","unstructured":"Frittoli, M. C. et al. Bone marrow as a source of hematopoietic stem cells for human gene therapy of \u03b2-thalassemia. Hum. Gene Ther. 22, 507\u201313 (2011).","journal-title":"Hum. Gene Ther."},{"key":"48078_CR56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00223-010-9365-0","volume":"86","author":"MG Vogiatzi","year":"2010","unstructured":"Vogiatzi, M. G. et al. Changes in bone microarchitecture and biomechanical properties in the th3 thalassemia mouse are associated with decreased bone turnover and occur during the period of bone accrual. Calcif. Tissue Int. 86, 484\u201394 (2010).","journal-title":"Calcif. Tissue Int."},{"key":"48078_CR57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI9459","volume":"105","author":"TH Bestor","year":"2000","unstructured":"Bestor, T. H. Gene silencing as a threat to the success of gene therapy. J. Clin. Invest. 105, 409\u2013411 (2000).","journal-title":"J. Clin. Invest."},{"key":"48078_CR58","first-page":"1","volume":"165","author":"GD Ginder","year":"2014","unstructured":"Ginder, G. D. Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl. Res. 165, 1\u201311 (2014).","journal-title":"Transl. Res."},{"key":"48078_CR59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2015.05.004","volume":"55","author":"D Costa","year":"2015","unstructured":"Costa, D., Capuano, M., Sommese, L. & Napoli, C. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies. Blood Cells, Mol. Dis. 55, 95\u2013100 (2015).","journal-title":"Blood Cells, Mol. Dis."},{"key":"48078_CR60","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson, L. J. et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 22, 2171\u20132179 (2001).","journal-title":"Eur. Heart J."},{"key":"48078_CR61","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hoc.2010.08.015","volume":"24","author":"JB Porter","year":"2010","unstructured":"Porter, J. B. & Shah, F. T. Iron overload in thalassemia and related conditions: Therapeutic goals and assessment of response to chelation therapies. Hematology\/Oncology Clinics of North America 24, 1109\u20131130 (2010).","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"1","key":"48078_CR62","doi-asserted-by":"crossref","first-page":"e28569","DOI":"10.1371\/journal.pone.0028569","volume":"7","author":"Daniel J. Stuckey","year":"2012","unstructured":"Stuckey, D. J. et al. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One 7 (2012).","journal-title":"PLoS ONE"},{"key":"48078_CR63","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/scd.2008.0028","volume":"17","author":"DM Delo","year":"2008","unstructured":"Delo, D. M. et al. Non-invasive longitudinal tracking of human amniotic fluid stem cells in the mouse heart. Stem Cells Dev. 17, 1185\u201394 (2008).","journal-title":"Stem Cells Dev."},{"key":"48078_CR64","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.19082\/5609","volume":"9","author":"N Ali","year":"2017","unstructured":"Ali, N. Iron overload assessment in \u03b2 Thalassemia Major - is T2* Magnetic Resonance Imaging the answer? Electron. physician 9, 5609\u20135610 (2017).","journal-title":"Electron. physician"},{"key":"48078_CR65","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000251907","volume":"31","author":"LC Hutton","year":"2009","unstructured":"Hutton, L. C., Ratnayake, U., Shields, A. & Walker, D. W. Neuropathology and Functional Deficits in a Model of Birth Asphyxia in the Precocial Spiny Mouse (Acomys cahirinus). Dev. Neurosci. 31, 523\u2013535 (2009).","journal-title":"Dev. Neurosci."},{"key":"48078_CR66","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.gt.3302632","volume":"12","author":"C Coutelle","year":"2005","unstructured":"Coutelle, C. et al. Gene therapy progress and prospects: fetal gene therapy\u2013first proofs of concept\u2013some adverse effects. Gene Ther. 12, 1601\u20131607 (2005).","journal-title":"Gene Ther."},{"key":"48078_CR67","first-page":"432","volume":"9","author":"SN Waddington","year":"2007","unstructured":"Waddington, S. N. et al. Fetal gene transfer. Curr. Opin. Mol. Ther. 9, 432\u20138 (2007).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"48078_CR68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2016.01.017","volume":"22","author":"MM Boelig","year":"2016","unstructured":"Boelig, M. M. et al. The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant. 22, 991\u2013999 (2016).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"48078_CR69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/hum.2016.007","volume":"27","author":"O Negre","year":"2016","unstructured":"Negre, O. et al. Gene Therapy of the \u03b2-Hemoglobinopathies by Lentiviral Transfer of the \u03b2(A(T87Q))-Globin Gene. Hum. Gene Ther. 27, 148\u201365 (2016).","journal-title":"Hum. Gene Ther."},{"key":"48078_CR70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fphar.2014.00270","volume":"5","author":"DL Ramachandra","year":"2014","unstructured":"Ramachandra, D. L. et al. In utero therapy for congenital disorders using amniotic fluid stem cells. Front. Pharmacol. 5, 270 (2014).","journal-title":"Front. Pharmacol."},{"key":"48078_CR71","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bpobgyn.2004.06.006","volume":"18","author":"AW Flake","year":"2004","unstructured":"Flake, A. W. In utero stem cell transplantation. Best Pract. Res. Clin. Obstet. Gynaecol. 18, 941\u201358 (2004).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"48078_CR72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.gt.3302130","volume":"11","author":"D Peebles","year":"2004","unstructured":"Peebles, D. et al. Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Ther. 11, 70\u20138 (2004).","journal-title":"Gene Ther."},{"key":"48078_CR73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40778-018-0117-9","volume":"4","author":"HA Hartman","year":"2018","unstructured":"Hartman, H. A., Rossidis, A. C. & Peranteau, W. H. In Utero Gene Therapy and Genome Editing. Curr. Stem Cell Reports 4, 52\u201360 (2018).","journal-title":"Curr. Stem Cell Reports"},{"key":"48078_CR74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0034-1382260","volume":"24","author":"SP Loukogeorgakis","year":"2014","unstructured":"Loukogeorgakis, S. P. & Flake, A. W. In utero stem cell and gene therapy: current status and future perspectives. Eur. J. Pediatr. Surg. 24, 237\u201345 (2014).","journal-title":"Eur. J. Pediatr. Surg."},{"key":"48078_CR75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bpobgyn.2015.08.006","volume":"31","author":"LE McClain","year":"2016","unstructured":"McClain, L. E. & Flake, A. W. In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application. Best Pract. Res. Clin. Obstet. Gynaecol. 31, 88\u201398 (2016).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"48078_CR76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/aja.1001990303","volume":"199","author":"RR Polakowska","year":"1994","unstructured":"Polakowska, R. R., Piacentini, M., Bartlett, R., Goldsmith, L. A. & Haake, A. R. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev. Dyn. 199, 176\u201388 (1994).","journal-title":"Dev. Dyn."},{"key":"48078_CR77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/gt.2011.135","volume":"19","author":"M Endo","year":"2012","unstructured":"Endo, M. et al. Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa. Gene Ther. 19, 561\u20139 (2012).","journal-title":"Gene Ther."},{"key":"48078_CR78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno, C. S. et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342\u20137 (2006).","journal-title":"Nat. Med."},{"key":"48078_CR79","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2011.107","volume":"19","author":"CNZ Mattar","year":"2011","unstructured":"Mattar, C. N. Z. et al. Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol. Ther. 19, 1950\u201360 (2011).","journal-title":"Mol. Ther."},{"key":"48078_CR80","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani, A. C. et al. Adenovirus-Associated Virus Vector\u2013Mediated Gene Transfer in Hemophilia B. N. Engl. J. Med. 365, 2357\u20132365 (2011).","journal-title":"N. Engl. J. Med."},{"key":"48078_CR81","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","volume":"107","author":"AC Nathwani","year":"2006","unstructured":"Nathwani, A. C. et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107, 2653\u201361 (2006).","journal-title":"Blood"},{"key":"48078_CR82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1098\/rspb.1956.0073","volume":"146","author":"RE Billingham","year":"1956","unstructured":"Billingham, R. E. & Brent, L. Acquired tolerance of foreign cells in newborn animals. Proc. R. Soc. Lond. B. Biol. Sci. 146, 78\u201390 (1956).","journal-title":"Proc. R. Soc. Lond. B. Biol. Sci."},{"key":"48078_CR83","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","volume":"172","author":"RE Billingham","year":"1953","unstructured":"Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 172, 603\u20136 (1953).","journal-title":"Nature"},{"key":"48078_CR84","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.mt.6300219","volume":"15","author":"DE Sabatino","year":"2007","unstructured":"Sabatino, D. E. et al. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol. Ther. 15, 1677\u201385 (2007).","journal-title":"Mol. Ther."},{"key":"48078_CR85","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1182\/blood-2015-03-636803","volume":"126","author":"WH Peranteau","year":"2015","unstructured":"Peranteau, W. H. et al. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants. Blood 126, 1245\u201354 (2015).","journal-title":"Blood"},{"key":"48078_CR86","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood-2002-01-0166","volume":"100","author":"WH Peranteau","year":"2002","unstructured":"Peranteau, W. H., Hayashi, S., Hsieh, M., Shaaban, A. F. & Flake, A. W. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 100, 2225\u201334 (2002).","journal-title":"Blood"},{"key":"48078_CR87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/aji.12083","volume":"69","author":"TD Burt","year":"2013","unstructured":"Burt, T. D. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am. J. Reprod. Immunol. 69, 346\u201358 (2013).","journal-title":"Am. J. Reprod. Immunol."},{"key":"48078_CR88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood-2002-03-0779","volume":"101","author":"SN Waddington","year":"2003","unstructured":"Waddington, S. N. et al. In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood 101, 1359\u201366 (2003).","journal-title":"Blood"},{"key":"48078_CR89","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.celrep.2014.09.013","volume":"9","author":"S Co\u015fxkun","year":"2014","unstructured":"Co\u015fxkun, S. et al. Development of the fetal bone marrow niche and regulation of HSC quiescence and homing ability by emerging osteolineage cells. Cell Rep. 9, 581\u2013590 (2014).","journal-title":"Cell Rep."},{"key":"48078_CR90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ar.1091200104","volume":"120","author":"EM Otis","year":"1954","unstructured":"Otis, E. M. & Brent, R. Equivalent ages in mouse and human embryos. Anat. Rec. 120, 33\u201363 (1954).","journal-title":"Anat. Rec."},{"key":"48078_CR91","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2002-05-1423","volume":"101","author":"C Klein","year":"2003","unstructured":"Klein, C. et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101, 2159\u201366 (2003).","journal-title":"Blood"},{"key":"48078_CR92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/asheducation.V2012.1.276.3807841","volume":"2012","author":"E Payen","year":"2012","unstructured":"Payen, E. & Leboulch, P. Advances in stem cell transplantation and gene therapy in the \u03b2-hemoglobinopathies. Hematology Am. Soc. Hematol. Educ. Program 2012, 276\u201383 (2012).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"48078_CR93","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00277-016-2620-3","volume":"95","author":"M Zafari","year":"2016","unstructured":"Zafari, M. et al. Non-invasive prenatal diagnosis of \u03b2-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis. Ann. Hematol. 95, 1341\u20131350 (2016).","journal-title":"Ann. Hematol."},{"key":"48078_CR94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.bmt.1705287","volume":"37","author":"W-L Ho","year":"2006","unstructured":"Ho, W.-L. et al. Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan. Bone Marrow Transplant. 37, 569\u201374 (2006).","journal-title":"Bone Marrow Transplant."},{"key":"48078_CR95","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-3-29","volume":"3","author":"A Riewpaiboon","year":"2010","unstructured":"Riewpaiboon, A. et al. Economic burden of beta-thalassemia\/Hb E and beta-thalassemia major in Thai children. BMC Res. Notes 3, 29 (2010).","journal-title":"BMC Res. Notes"},{"key":"48078_CR96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2257.1999.00262.x","volume":"21","author":"J Karnon","year":"1999","unstructured":"Karnon, J. et al. Lifetime treatment costs of beta-thalassaemia major. Clin. Lab. Haematol. 21, 377\u201385 (1999).","journal-title":"Clin. Lab. Haematol."},{"key":"48078_CR97","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtm.2018.03.002","volume":"9","author":"V Poletti","year":"2018","unstructured":"Poletti, V. et al. Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Mol. Ther. - Methods Clin. Dev. 9, 257\u2013269 (2018).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"issue":"Spec No","key":"48078_CR98","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/hmg\/5.Supplement_1.1397","volume":"5","author":"U Blomer","year":"1996","unstructured":"Blomer, U., Naldini, L., Verma, I. M., Trono, D. & Gage, F. H. Applications of gene therapy to the CNS. Hum. Mol. Genet. 5(Spec No), 1397\u20131404 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"48078_CR99","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jcb.21507","volume":"102","author":"MC Mahajan","year":"2007","unstructured":"Mahajan, M. C., Karmakar, S. & Weissman, S. M. Control of beta globin genes. Journal of Cellular Biochemistry 102, 801\u2013810 (2007).","journal-title":"Journal of Cellular Biochemistry"},{"key":"48078_CR100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/asheducation-2010.1.445","volume":"2010","author":"P Arumugam","year":"2010","unstructured":"Arumugam, P. & Malik, P. Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside. Hematology 2010, 445\u2013450 (2010).","journal-title":"Hematology"},{"key":"48078_CR101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/chim.2.2.16287","volume":"2","author":"A Nijagal","year":"2011","unstructured":"Nijagal, A., Wegorzewska, M., Le, T., Tang, Q. & MacKenzie, T. C. The maternal immune response inhibits the success of in utero hematopoietic cell transplantation. Chimerism 2, 55\u201357 (2011).","journal-title":"Chimerism"},{"key":"48078_CR102","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI44907","volume":"121","author":"A Nijagal","year":"2011","unstructured":"Nijagal, A. et al. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J. Clin. Invest. 121, 582\u201392 (2011).","journal-title":"J. Clin. Invest."},{"key":"48078_CR103","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.1302403","volume":"192","author":"M Wegorzewska","year":"2014","unstructured":"Wegorzewska, M. et al. Fetal Intervention Increases Maternal T Cell Awareness of the Foreign Conceptus and Can Lead to Immune-Mediated Fetal Demise. J. Immunol. 192, 1938\u201345 (2014).","journal-title":"J. Immunol."},{"key":"48078_CR104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clp.2012.04.004","volume":"39","author":"A Nijagal","year":"2012","unstructured":"Nijagal, A., Flake, A. W. & MacKenzie, T. C. In utero hematopoietic cell transplantation for the treatment of congenital anomalies. Clin. Perinatol. 39, 301\u201310 (2012).","journal-title":"Clin. Perinatol."},{"key":"48078_CR105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2144\/01311rr04","volume":"31","author":"DJ Ingham","year":"2001","unstructured":"Ingham, D. J., Beer, S., Money, S. & Hansen, G. Quantitative real-time PCR assay for determining transgene copy number in transformed plants. Biotechniques 31, 132\u2013140 (2001).","journal-title":"Biotechniques"},{"key":"48078_CR106","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.gt.3302440","volume":"12","author":"S Charrier","year":"2005","unstructured":"Charrier, S. et al. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther. 12, 597\u2013606 (2005).","journal-title":"Gene Ther."},{"key":"48078_CR107","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2342-10-1","volume":"10","author":"E Heiberg","year":"2010","unstructured":"Heiberg, E. et al. Design and validation of Segment - freely available software for cardiovascular image analysis. BMC Med. Imaging 10, 1 (2010).","journal-title":"BMC Med. Imaging"}],"updated-by":[{"DOI":"10.1038\/s41598-019-55754-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48078-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:26:48Z","timestamp":1671280008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48078"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48078-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-55754-y","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11592"}}